… to the advancement of applied health economics. In order to promote policy-relevant health economic research, the division explicitly endorses an approach that is characterized by theoretical and methodological pluralism. Specifically, this entails the development of novel models and methods for the valuation of health and health care, and it includes analysis of social expectations.

… to better understanding of the economics of cancer care. The Division examines factors that influence the costs of cancer as a whole, the economic consequences of particular cancer types, and the costs of interventions aimed at their prevention, diagnosis, and treatment. Particular consideration is given to factors that affect the burden and cost of cancer care related to gender, age, and socioeconomic background.

… to improvements in the effectiveness and efficiency of medical care for cancer patients. The Division aims to provide health care policy makers with robust information on the incremental costs and benefits of medical technologies. This may include developing new analytical methods, as the currently prevailing logic of cost-effectiveness does not capture the full value of health, health gains, and health care from a citizen's perspective.

• Burden of disease studies,
  addressing cancer related burden of disease, attributable cost of illness, and budget impact of interventions, from the perspectives of society as a whole as well as those of payers and patients;
• Cost value analyses,
  including (1) cost effectiveness, (2) cost utility, (3) cost benefit, and (4) social cost value studies of intervention strategies in cancer prevention, screening, diagnosis, treatment, and care;
• Economic methods and Social Costs Value Analysis (SCVA),
  exploring the conceptual and empirical underpinnings of economic analyses and furthering the development of health economic evaluation methods that better capture citizens’ social norms and preferences.

... Outreach activities

• Health Economics Summer School
• Open Seminars
• Collaboration with clinicians: Cost-effectiveness analysis alongside clinical trials
• Other outreach activities